Esskays Pharma Private Limited
About Esskays Pharma Private Limited
Data last updated:
Esskays Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2021PTC377285.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Hitesh Malhotra and Salesh Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Building Number – 32 3rd Floor Mezzanine, Punjab.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.88 Lakh, a decline of 42% compared to the previous year. For the same year it recorded a net loss of ₹1.45 Lakh (net margin -2.1%) and EBITDA of ₹3.5 Lakh (EBITDA margin 5.1%).
As per MCA filings, the company has open charges of ₹4 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBuilding Number – 32 3rd Floor Mezzanine, North West Avenue Road Punjabi Bagh (Club Road), New Delhi, Delhi, India – 110026
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Esskays Pharma Private Limited
The main business activity of Esskays Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Esskays Pharma Private Limited FY 2025 filings available
Esskays Pharma Private Limited reported revenue of ₹68.88 Lakh (down 42% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Esskays Pharma Private Limited
Revenue fell 42% in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Esskays Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.5 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.45 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Esskays Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Esskays Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Esskays Pharma Private Limited
Esskays Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hitesh Malhotra Also directs: Ujjwal Finance Private Limited | Director | 06 Feb 2025 | 1 Years 8 Months | Current |
| Salesh Gupta Also directs: Faith Management Services Private Limited | Director | 06 Feb 2025 | 1 Years 8 Months | Current |
Peer Comparison of Esskays Pharma Private Limited
Esskays Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chintalapati Holdings Private Limited | ₹69.21 Lakh (FY 2024) | •••• | •••• | -99.0% | •••• | Hyderabad, Telangana, India |
| Reagenta Pharmaceuticals Private Limited | ₹69.17 Lakh (FY 2025) | •••• | •••• | 56.0% | •••• | Mumbai, Maharashtra, India |
| Zhenpi Life Sciences Private Limited | ₹69.16 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Delhi, India |
| Aashirwad Chlorofins Private Limited | ₹69.15 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Panipat, Haryana, India |
| Prophex Healthcare Private Limited | ₹69.09 Lakh (FY 2022) | •••• | •••• | -22.0% | •••• | Chennai, Tamil Nadu, India |
| Esskays Pharma Private Limited this company | ₹68.88 Lakh (FY 2025) | •••• | •••• | -42.0% | •••• | New Delhi, Delhi, India |
| Mindvision Pharmaceutical Private Limited | ₹68.82 Lakh (FY 2025) | •••• | •••• | 50.0% | •••• | Lucknow, Uttar Pradesh, India |
| Dei Gratia Labs Private Limited | ₹68.82 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Meerut, Uttar Pradesh, India |
| Decisive Pharma Private Limited | ₹68.75 Lakh (FY 2025) | •••• | •••• | -37.0% | •••• | Haryana, India |
| Alchemist Hospitals (Gurgaon) Private Limited | ₹68.7 Lakh (FY 2018) | •••• | •••• | -53.0% | •••• | Panchkula, Haryana, India |
| Atreya Resorts for Traditional Healing Private Limited | ₹68.68 Lakh (FY 2024) | •••• | •••• | 52.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Esskays Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Esskays Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 2023 | Hdfc Bank Limited | ₹4 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Esskays Pharma Private Limited
Employment history and EPFO contributions of people linked to Esskays Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Esskays Pharma Private Limited
Esskays Pharma Private Limited has 5 board changes on record since 2025: 2 appointments and 3 cessations. The latest: Jatin Saigal ceased to be Director on 10 Feb 2025.
Credit Ratings, Litigation & Regulatory Alerts for Esskays Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Esskays Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Esskays Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Esskays Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Esskays Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Esskays Pharma Private Limited
Esskays Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 2021 (5+ years old) and is registered under CIN U24299DL2021PTC377285.
Esskays Pharma reported revenue of ₹68.88 Lakh for FY 2025 (down 42% YoY).
Esskays Pharma has 2 current directors:
- Hitesh Malhotra - Director
- Salesh Gupta - Director
Esskays Pharma reported a net loss of ₹1.45 Lakh (net margin -2.1%) and EBITDA of ₹3.5 Lakh (EBITDA margin 5.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Esskays Pharma is U24299DL2021PTC377285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Esskays Pharma was incorporated on 19 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Esskays Pharma by revenue are Chintalapati Holdings Private Limited, Reagenta Pharmaceuticals Private Limited, Zhenpi Life Sciences Private Limited, Aashirwad Chlorofins Private Limited, Prophex Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Jatin Saigal ceased to be Director on 10 Feb 2025. Karan Sehgal ceased to be Director on 10 Feb 2025. Satvik Sehgal ceased to be Director on 10 Feb 2025. Esskays Pharma has 5 board changes on record in total.
The registered office of Esskays Pharma is at Building Number – 32 3rd Floor Mezzanine, North West Avenue Road Punjabi Bagh Club Road, New Delhi, Delhi, India – 110026.
Esskays Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh.
Esskays Pharma operates in the pharma industry, in the drug formulation and development segment.